arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

download Export Data

CERO THERAPEUTICS HOLDINGS, INC.

CERO

— Price unavailable

21 Visible periods

22 Metrics

Absolute Benchmarks

Price Chart

Health

Weak

Bearish Absolute basis

auto_awesome

Analytical Summary

On an absolute basis, CERO THERAPEUTICS HOLDINGS, INC. shows weak fundamentals, weighed down by FCF / Net Income. These readings use fixed quality thresholds rather than peer benchmarks, because too few comparable companies are available to rank against.

Market Cap —

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC 42.0%

FCF / Share $0.10

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity -0.01

info Valuation on last close.

21-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$-5.89M

↓ -15.3% —

info Signals below are graded against fixed quality thresholds, not peers — peer ranking needs more comparable companies.

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

FCF / Net IncomeFCF / Net Income of 0.81x is caution on an absolute basis (target > 1x)

Health Breakdown

Cash Quality ↓

Dividend History

Dividend / share · sourced from SEC filings

$10.37 Latest / share

FY 2020

FY 2021

FY 2022

FY 2023

FY 2024

$10.37

FY 2025

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q4 FY2020 Jun 7, 2021 10-K ↗
EPS Growth YoY (%)	87.4% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	—	99.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-102750.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-2550.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	77.8% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-15.3% Weak ↑ Weak Improving Year-over-year change in net income	N/M	-846.7% Weak → Weak Stable Year-over-year change in net income	-846.7% Weak ↓ Weak Declining Year-over-year change in net income	-792.3% Weak ↓ Weak Declining Year-over-year change in net income	N/M	-18.8% Weak ↑ Weak Improving Year-over-year change in net income	-18.8% Weak ↑ Weak Improving Year-over-year change in net income	76.5% Excellent ↑ Excellent Improving Year-over-year change in net income	-1817.2% Weak ↓ Weak Declining Year-over-year change in net income	-27.4% Weak ↑ Weak Improving Year-over-year change in net income	-27.4% Weak ↑ Weak Improving Year-over-year change in net income	-545.1% Weak ↑ Weak Improving Year-over-year change in net income	—	-37699.7% Weak Weak Year-over-year change in net income	-37699.7% Weak Weak Year-over-year change in net income	—	—	—	—	—

💰 Are margins durable? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q4 FY2020 Jun 7, 2021 10-K ↗
Effective Tax Rate (%) (%)	—	—	—	—	—	—	—	—	—	—	-8.4% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-3.2% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	195.2% Weak Weak Actual taxes paid relative to pre-tax income Optimal: 15-25%	41.7% Weak Weak Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—
FCF / Net Income (x)	-0.48x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—	—	—	—	—	0.53x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.83x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	—	1.42x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	—	0.63x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.82x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.00x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q4 FY2020 Jun 7, 2021 10-K ↗
Return on Invested Capital (%)	42.0% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	—	75.9% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	228.4% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	1187.3% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	87.4% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	—	28.6% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	17.8% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	9.6% Fair ↑ Fair Improving Return earned on debt + equity capital invested Optimal: > 10%	3.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	12.0% Good Good Return earned on debt + equity capital invested Optimal: > 10%	—	-11.1% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	3.6% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—	—
Return on Capital (%) (%)	-219.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	—	-111.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-76.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-61.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-33.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	—	-12.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-9.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-99.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-5.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-10.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	-3.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—	—	—
Return on Common Equity (%) (%)	63.6% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+324%)	83.4% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+456%)	119.2% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+695%)	—	—	-35.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-336%)	—	23.1% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+54%)	14.4% Fair ↑ Fair Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: At sector avg	12.0% Fair ↑ Fair Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-20%)	3.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-77%)	3.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-76%)	—	2.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-84%)	4.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-72%)	4.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-69%)	4.7% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-69%)	—	-4.2% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-128%)	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q4 FY2020 Jun 7, 2021 10-K ↗
Debt to Equity (x)	-0.01x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-102%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Interest Coverage (x)	—	—	—	—	—	—	—	—	-186.71x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	-152396.62x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—	—
Net Debt (USD)	$136.76K	—	$-1.90M	$-3.20M	$-5.10M	—	—	—	—	—	$-119.01K	—	—	$-475.87K	—	—	—	$-1.10M	$0.00	—	$0.00
Debt / EBITDA (x)	-0.03x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

📊 What does each share earn? 5 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q4 FY2020 Jun 7, 2021 10-K ↗
Basic EPS, GAAP (USD)	$-0.20	—	$-9.10	$-61.71	$-1.59	$542.12	$-1.96K	$-0.06	$-0.06	—	—	—	$-0.27	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$0.10	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$-0.32	—	$-3.59	$-3.35	$-0.10	—	—	$-0.27	$-0.44	—	—	—	—	—	—	—	—	—	—	—	—
Tangible Book Value per Share (USD)	$-0.32	—	$-3.59	$-3.35	$-0.10	—	—	$-0.27	$-0.44	—	—	—	—	—	—	—	—	—	—	—	—
Basic Weighted Avg Shares (shares)	28.76M	—	1.26M	488,076	3.43M	—	292	9.07M	9.07M	—	—	—	9.06M	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q4 FY2020 Jun 7, 2021 10-K ↗
Working Capital (USD)	$-9.75M	$-6.35M	$-5.90M	$-3.37M	$-2.09M	$-3.69M	—	$-4.53M	$-6.15M	$-1.54M	—	—	—	—	$-90.68K	—	$922.95K	$1.26M	$-253.00K	—	—
LT Debt (USD)	$136.76K	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Total Equity (USD)	$-9.26M	$-5.45M	$-4.54M	$-1.63M	$-329.39K	$-1.89M	—	$-2.48M	$-3.98M	$-42.06M	$-13.77M	$-13.29M	—	$-11.00M	$-9.06M	$-8.16M	$-8.05M	$-7.67M	$24.00K	$0.00	$0.00

📋 What is driving earnings? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q4 FY2020 Jun 7, 2021 10-K ↗
Depreciation Expense (USD)	—	—	$69.35K	$76.29K	$76.29K	—	$113.86K	$37.36K	$37.36K	—	—	—	$115.39K	—	—	—	—	—	—	—	—
Net Income, GAAP (USD)	$-5.89M	$-4.54M	$-5.42M	$-5.42M	$-5.11M	$671.89K	$-572.21K	$-572.21K	$-572.21K	$-5.04M	$-481.71K	$-481.71K	$-2.44M	$-262.68K	$-378.00K	$-378.00K	$-378.00K	—	$-1.00K	$-1.00K	—
Operating Cash Flow (USD)	$2.80M	—	—	—	—	—	—	—	—	—	$-256.12K	$-883.10K	—	$-373.10K	—	$-236.71K	$-308.09K	—	—	$0.00	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 6 years · 21 quarters

CERO THERAPEUTICS HOLDINGS, INC.

Analytical Summary

21-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Dividend History

Statement lens

Benchmark Lens

Benchmarks unavailable

Compare CERO with peers